WHERE ARE WE NOW? WHERE ARE WE GOING?

While treatment for HIV has become more effective and less complicated in recent years, it still involves taking a pill or pills each day for life. But innovative new products could revolutionize HIV treatment and prevention.

Sometimes called long-acting agents, these products may take different forms, ranging from injections to implants to oral medications, and they would not require daily dosing. Some might require a monthly dose, while others could be administered a few times a year.

Taking an idea and turning it into a desirable, effective, affordable, and accessible product is a long and difficult process.

Several pharmaceutical manufacturers areactively engaged in developing innovative new therapies both to treat and to prevent HIV. If successful, new long-acting products that do not require daily dosing could become available within the next few years.

Only one product is currently available, but several agents are in various stages of the research pipeline. Many people living with HIV and other stakeholders are excited by these new products, wondering if they could be a game changer in our ability to move much closer to ending the HIV epidemic in the United States and around the world.

Our meeting will be Tuesday, June 25 at 5:30pm.

It’ll be held on the 2nd Floor of the West Clinic at Harborview Medical Center, down the hall from Madison Clinic.

We’ll provide dinner for you. We can cover parking in the Harborview View Park Garage. Bus tickets are also available.

And you can RSVP for this meeting right here on this Facebook event page!